Newsfeeds Archive - Spark Newswire

2 minute read

Third Harmonic Bio Appoints Christopher Murphy As Chief Financial And Business Officer And Provides Business Update

January 4, 9:06 AM

Chris brings extensive enterprise-level leadership experience in business development, commercial operations, and corporate strategy IND-enabling toxicology studies of THB335 nearing completion; Pre-IND interaction

THRD

1 minute read

Earnings

Third Harmonic Bio: Q3 Earnings Insights

By Benzinga Insights

November 9, 9:55 AM

Third Harmonic Bio (NASDAQ:THRD) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:00 PM. Here’s…

THRD

1 minute read

Third Harmonic Bio Announces Q2 2023 Financial Results; Financial Position With Cash And Cash Equivalents Totaling $278.1M As Of June 30, 2023

By Happy Mohamed

August 10, 8:22 AM

Summary of Financial Results Cash Position: Cash and cash equivalents totaled $278.1 million as of June 30, 2023. Based on the company's current operating plan, Third Harmonic Bio believes that

THRD

4 minute read

Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335

By Happy Mohamed

July 25, 8:42 AM

THB335 retains selectivity and potency of first-generation oral KIT inhibitor, THB001, with differentiated metabolic, distribution and physicochemical profile THB001 demonstrated evidence of pharmacodynamic (PD)

THRD

2 minute read

Top 5 Health Care Stocks That May Rally

By Lisa Levin

February 3, 2:35 PM

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

AMGN

2 minute read

5 Cheapest Health Care Stocks You Should Think About

By Lisa Levin

January 27, 9:48 AM

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

ABBV

3 minute read

Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

December 15, 2:28 PM

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.

AGYS

14 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

December 15, 12:19 PM

On Thursday, 241 companies hit new 52-week lows.

ACHL

1 minute read

Third Harmonic Bio Stock Plummets After Trial Discontinuation On Safety Concerns

By Vandana Singh

December 15, 11:10 AM

Third Harmonic Bio Inc (NASDAQ:THRD) will discontinue the ongoing Phase 1b study of THB001 in chronic inducible urticaria, after observing asymptomatic…

THRD

1 minute read

Third Harmonic Bio Announces Discontinuation Of Phase 1b Study Of THB001 In Chronic Inducible Urticaria

By Benzinga Newsdesk

December 15, 8:07 AM

-- Company decision follows observation of asymptomatic liver transaminitis in two subjects enrolled in first dose cohort of 200mg BID -- Evidence of clinical activity observed; full data set to be presented at

THRD